secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001437749-24-027511
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva prices $5.0M at-the-market offering of common stock and warrants
-----------------------------------------------------------------------

- Offering comprises 4,761,905 shares (or pre-funded warrants) plus warrants for same number; combined price $1.05 per unit.
- Warrants exercisable at $0.7964/share, expire 5 years from issuance; pre-funded warrants at $0.0001/share.
- Existing warrants for up to 4,736,561 shares amended to $0.7964 exercise price and 5-year term for $0.125 per warrant.
- Net proceeds expected to fund Phase 3 RECOVER-2 trial and working capital; gross proceeds ~$5.0M.
- Titan Partners Group is sole bookrunner; closing expected August 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924027511/0001437749-24-027511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924027511/rvph20240821_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-027511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer